3 - 10 days
ALK (2p23) by FISH for NSCLC
Crizotinib evaluation for Non-small cell lung cancer (NSCLC)
Looking to order a test?
We’ve provided helpful links to make ordering easy.Find a Requisition
All specimens should be accompanied by a requisition.Submitting Specimens
Learn about how to properly label and where to ship specimens.Order Kits and Supplies
MLabs provides all the supplies necessary for the collection of specimens.Test FAQ
Visit our provider FAQ and learn about common questions to ordering tests.
Fluorescence In Situ Hybridization (FISH)
This test detects rearrangements involving the ALK gene (2p23) via fluorescence in situ hybridization (FISH) in formalin-fixed paraffin-embedded (FFPE) non-small cell lung cancer (NSCLC) tissue specimens. This test is FDA-approved to aid in identifying those patients eligible for treatment with crizotinib, a small molecule inhibitor of the ALK tyrosine kinase. FISH is performed using a dual color break apart probe (Abbott Molecular) to qualitatively assess for the presence of ALK gene rearrangements. This test is intended only for NSCLC tissue specimens that have been fixed in 10% neutral buffered formalin and embedded in paraffin.
Interpretive report provided. This test detects the Apo E2, E3, and E4 genes.
* Reference ranges may change over time. Please refer to the original patient report when evaluating results.
A formalin-fixed, paraffin-embedded tissue block containing sufficient neoplastic cells is preferred. Unstained slides (3, 4-micron slides) with associated H&E stained slide are also acceptable. Decalcified tissue or other fixatives will be accepted and the assay attempted, however these may result in failed testing due to degraded nucleic acid. Both blocks and slides should be stored at room temperature.